abstract |
An anti-IL-12 antibody is disclosed with its antigen binding portion. One or more methods of separating and purifying anti-IL-12 antibodies from a sample matrix are provided. This isolated anti-IL-12 antibody can be used in research and development as well as in the clinical environment. Also disclosed are pharmaceutical compositions comprising isolated anti-IL-12 antibodies. |